Development and Initial Evaluation of a Multifaceted Intervention to Improve Mental Health and Quality of Life Among Prostate Cancer Survivors

Mental health issues affect a third of prostate cancer (PCa) survivors. Here, we describe the development and preliminary evaluation of a unique multifaceted intervention, the Prostate Cancer–Patient Empowerment Program (PC-PEP), designed to improve mental health and quality of life among survivors....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of mental health and addiction 2020-08, Vol.18 (4), p.1067-1080
Hauptverfasser: Ilie, Gabriela, Mason, Ross, Bell, David, Bailly, Greg, Rendon, Ricardo A., Mann, Robert, Lawen, Joseph G., Bowes, David, Wilke, Derek, Patil, Nikhilesh, Rutledge, Robert D. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mental health issues affect a third of prostate cancer (PCa) survivors. Here, we describe the development and preliminary evaluation of a unique multifaceted intervention, the Prostate Cancer–Patient Empowerment Program (PC-PEP), designed to improve mental health and quality of life among survivors. The 28-day pilot PC-PEP Intervention was developed following the engagement of patients, survivors, caregivers and health care professionals In identifying survivorship needs and well-being resources for improved mental health. The pilot intervention was implemented with a group of 30 PCa survivors in Halifax, Canada. Measures collected over the 28-day program included psychological distress and physical health indicators, as well as program compliance. Participation in PC-PEP resulted in significant improvement in measures of mental and physical health over the 28-day program. Very good to excellent compliance with all five components of PC-PEP was observed. This evaluation provides strong initial support for a multifaceted program to improve mental health outcomes in prostate cancer survivors.
ISSN:1557-1874
1557-1882
DOI:10.1007/s11469-019-00108-y